Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.24.1.1.u2
SHARE CAPITAL (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

  

   

March 31,

2024

   

March 31,

2023

 
Warrants     6,218,226       250,759  
Options     61,712       27,653  
Convertible debentures     39,475,584       227,171  
Total anti-dilutive weighted average shares     45,755,522       505,583